CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agreement (JDA) with T&R Biofab to develop alternative meat using 3D bioprinting technology. T&R Biofab is a med-tech company that develops artificial tissues using its technology in the field of regenerative medicine based on 3D bioprinting.
Through this collaboration, the two Korean companies will leverage synergies between the food industry and the 3D-printing medical field to elevate new plant-based alternative protein products up to consumers' expectations on taste, texture, appearance and nutrition. Plant-based alternative-protein food products beyond the limitations of today's offerings are seen as new growth engines for both companies.